國立虎尾科技大學 |

Antibacterial Drug Discovery to Combat MDR = Natural Compounds, Nanotechnology and Novel Synthetic Sources /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Antibacterial Drug Discovery to Combat MDR/ edited by Iqbal Ahmad, Shamim Ahmad, Kendra P. Rumbaugh.
其他題名:	Natural Compounds, Nanotechnology and Novel Synthetic Sources /
其他作者:	Ahmad, Iqbal.
面頁冊數:	XII, 680 p. 63 illus., 31 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Medical microbiology. -
電子資源:	https://doi.org/10.1007/978-981-13-9871-1
ISBN:	9789811398711

Antibacterial Drug Discovery to Combat MDR = Natural Compounds, Nanotechnology and Novel Synthetic Sources /
Antibacterial Drug Discovery to Combat MDRNatural Compounds, Nanotechnology and Novel Synthetic Sources /[electronic resource] :edited by Iqbal Ahmad, Shamim Ahmad, Kendra P. Rumbaugh. - 1st ed. 2019. - XII, 680 p. 63 illus., 31 illus. in color.online resource.

Antibacterial drug discovery: perspective insights -- Section A: The Challenge of Antibiotic Resistance and Tolerance -- Problematic Groups of Multidrug Resistant Bacteria and their Resistance Mechanisms -- Emergence and spread of multi-drug resistance in ocular bacterial pathogens: A current update -- Antibiotic resistance in Campylobacter jejuni: mechanism, status and public health significance -- Mechanisms of biofilm development, antibiotic resistance & tolerance and their role in persistent infections -- Developing in vivo infection models with MDR pathogens for evaluating compound efficacy -- Section B. New antibiotic drug discovery approaches and progress -- Endophytes: a hidden treasure of novel antimicrobial metabolites -- Alternative therapies to antibiotics to combat drug-resistant bacterial pathogens -- In silico molecular modeling: key technologies in the drug discovery process to combat multidrug resistance -- Computational approaches for antibacterial drug discovery -- Efflux pump inhibitors and their role in the reversal of drug resistance -- Medicinal plants as a reservoir of new structures for anti-infective compounds -- Essential oils: Potential application in disease management -- Exploration of soil resistome through a metagenomic approach -- Actinomycetes as a continued source of new antibacterial leads -- Are Ancient Remedies the New Answer to Fighting Infections? -- Section C. Alternative antibiotic resistance treatment strategies -- Pre and probiotics: Using functional foods in the fight against microbial resistance to antibiotics -- Combination of drugs: an effective approach for enhancing the efficacy of antibiotics to combat drug resistance -- Targeted delivery of antibiotics using microparticles to combat multi-drug-resistant tuberculosis -- Practical applications of bacteriophage therapy: biofilms to bedside -- Inhibition of Quorum sensing; prospects in disease control -- Approaches for disrupting tissue-associated biofilms -- Nanomedicine and nanoemulsion in increasing the availability of antibiotics -- Nanoparticles as new emerging antibacterials: potential and limitation -- Nanomaterials as a novel class of anti-infective agents that attenuate bacterial quorum sensing -- Nanoparticle-based drug delivery systems: promising approaches against bacterial infections -- Green synthesis of metal nanoparticles: characterization and their antibacterial efficacy.

This book compiles the latest information in the field of antibacterial discovery, especially with regard to the looming threat of multi-drug resistance. The respective chapters highlight the discovery of new antibacterial and anti-infective compounds derived from microbes, plants, and other natural sources. The potential applications of nanotechnology to the fields of antibacterial discovery and drug delivery are also discussed, and one section of the book is dedicated to the use of computational tools and metagenomics in antibiotic drug discovery. Techniques for efficient drug delivery are also covered. The book provides a comprehensive overview of the progress made in both antibacterial discovery and delivery, making it a valuable resource for academic researchers, as well as those working in the pharmaceutical industry.

ISBN: 9789811398711

Standard No.: 10.1007/978-981-13-9871-1doiSubjects--Topical Terms:

583124
Medical microbiology.

LC Class. No.: QR46

Dewey Class. No.: 616.9041

Antibacterial Drug Discovery to Combat MDR = Natural Compounds, Nanotechnology and Novel Synthetic Sources /
LDR:04709nam a22003975i 4500 001 1008574
003 DE-He213
005 20200703135857.0
007 cr nn 008mamaa
008 210106s2019 si | s |||| 0|eng d
020 $a 9789811398711 $9 978-981-13-9871-1
024 7 $a 10.1007/978-981-13-9871-1 $2 doi
035 $a 978-981-13-9871-1
050 4 $a QR46
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 616.9041 $2 23
245 1 0 $a Antibacterial Drug Discovery to Combat MDR $h [electronic resource] : $b Natural Compounds, Nanotechnology and Novel Synthetic Sources / $c edited by Iqbal Ahmad, Shamim Ahmad, Kendra P. Rumbaugh.
250 $a 1st ed. 2019.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a XII, 680 p. 63 illus., 31 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Antibacterial drug discovery: perspective insights -- Section A: The Challenge of Antibiotic Resistance and Tolerance -- Problematic Groups of Multidrug Resistant Bacteria and their Resistance Mechanisms -- Emergence and spread of multi-drug resistance in ocular bacterial pathogens: A current update -- Antibiotic resistance in Campylobacter jejuni: mechanism, status and public health significance -- Mechanisms of biofilm development, antibiotic resistance & tolerance and their role in persistent infections -- Developing in vivo infection models with MDR pathogens for evaluating compound efficacy -- Section B. New antibiotic drug discovery approaches and progress -- Endophytes: a hidden treasure of novel antimicrobial metabolites -- Alternative therapies to antibiotics to combat drug-resistant bacterial pathogens -- In silico molecular modeling: key technologies in the drug discovery process to combat multidrug resistance -- Computational approaches for antibacterial drug discovery -- Efflux pump inhibitors and their role in the reversal of drug resistance -- Medicinal plants as a reservoir of new structures for anti-infective compounds -- Essential oils: Potential application in disease management -- Exploration of soil resistome through a metagenomic approach -- Actinomycetes as a continued source of new antibacterial leads -- Are Ancient Remedies the New Answer to Fighting Infections? -- Section C. Alternative antibiotic resistance treatment strategies -- Pre and probiotics: Using functional foods in the fight against microbial resistance to antibiotics -- Combination of drugs: an effective approach for enhancing the efficacy of antibiotics to combat drug resistance -- Targeted delivery of antibiotics using microparticles to combat multi-drug-resistant tuberculosis -- Practical applications of bacteriophage therapy: biofilms to bedside -- Inhibition of Quorum sensing; prospects in disease control -- Approaches for disrupting tissue-associated biofilms -- Nanomedicine and nanoemulsion in increasing the availability of antibiotics -- Nanoparticles as new emerging antibacterials: potential and limitation -- Nanomaterials as a novel class of anti-infective agents that attenuate bacterial quorum sensing -- Nanoparticle-based drug delivery systems: promising approaches against bacterial infections -- Green synthesis of metal nanoparticles: characterization and their antibacterial efficacy.
520 $a This book compiles the latest information in the field of antibacterial discovery, especially with regard to the looming threat of multi-drug resistance. The respective chapters highlight the discovery of new antibacterial and anti-infective compounds derived from microbes, plants, and other natural sources. The potential applications of nanotechnology to the fields of antibacterial discovery and drug delivery are also discussed, and one section of the book is dedicated to the use of computational tools and metagenomics in antibiotic drug discovery. Techniques for efficient drug delivery are also covered. The book provides a comprehensive overview of the progress made in both antibacterial discovery and delivery, making it a valuable resource for academic researchers, as well as those working in the pharmaceutical industry.
650 0 $a Medical microbiology. $3 583124
650 0 $a Pharmacology. $3 583819
650 0 $a Infectious diseases. $3 1102043
650 0 $a Bacteriology. $3 668505
650 0 $a Nanotechnology. $3 557660
650 1 4 $a Medical Microbiology. $3 668401
650 2 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Infectious Diseases. $3 668393
700 1 $a Ahmad, Iqbal. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 784073
700 1 $a Ahmad, Shamim. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1274273
700 1 $a Rumbaugh, Kendra P. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1302408
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811398704
776 0 8 $i Printed edition: $z 9789811398728
776 0 8 $i Printed edition: $z 9789811398735
856 4 0 $u https://doi.org/10.1007/978-981-13-9871-1
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)